PEAK3 and cancer: Analysis of the PEAK3 transcript level from TCGA transcriptomic data (gepia.cancer-pku.cn accessed on 2 January 2021) confirmed that PEAK3 was upregulated in AML (Figure 1c), particularly in the M4 and M5 subtypes (Figure S3a).